Author Question: What are the dreamlike experiences at the onset of sleep that are difficult to distinguish from ... (Read 129 times)

CORALGRILL2014

  • Hero Member
  • *****
  • Posts: 525
What are the dreamlike experiences at the onset of sleep that are difficult to distinguish from reality?
 
  a. hypnagogic hallucinations
   b. idiopathic hallucinations
  c. occipital illusions
  d. pseudo-psychedelic visions

Question 2

What does cataplexy involve?
 
  a. dreamlike experiences that the person has trouble distinguishing from reality
   b. an attack of muscle weakness while awake
  c. a lack of inhibition of movement during REM sleep
  d. repeated involuntary movement of the legs or arms during sleep



k2629

  • Sr. Member
  • ****
  • Posts: 357
Answer to Question 1

a

Answer to Question 2

b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

The average adult has about 21 square feet of skin.

Did you know?

All adults should have their cholesterol levels checked once every 5 years. During 2009–2010, 69.4% of Americans age 20 and older reported having their cholesterol checked within the last five years.

Did you know?

For about 100 years, scientists thought that peptic ulcers were caused by stress, spicy food, and alcohol. Later, researchers added stomach acid to the list of causes and began treating ulcers with antacids. Now it is known that peptic ulcers are predominantly caused by Helicobacter pylori, a spiral-shaped bacterium that normally exist in the stomach.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library